TB remains high in many low- and middle-income nations, and about 558,000 people in 2017 developed rifampicin-resistant TB.
The Nigeria Centre for Disease Control (NCDC) said today it is helping UK officials respond to their two recent monkeypox cases, which involve travelers from Nigeria, a country that has now reported 262 suspected cases.
Newer and repurposed drugs produced better results and fewer deaths than older treatments did.
The Coalition for Epidemic Preparedness Innovations (CEPI) recently announced a collaboration with Germany-based IDT Biologika worth up to $36 million to develop and produce a vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV).
The substitution of bedaquiline for second-line injectable antibiotics (SLIs) in a small group of patients with multidrug-resistant tuberculosis (MDR-TB) resulted in improved outcomes, South African researchers report in Clinical Infectious Diseases.
A study today in Pediatrics suggests that a dose of parenteral antibiotics prior to discharge from the emergency department (ED) is likely not necessary for most young children with urinary tract infections (UTIs).
The changes prioritize newer medications and oral regimens over injectable drugs.
The Democratic Republic of the Congo's (DRC's) ministry of health confirmed that the new Ebola outbreak in the eastern reaches of the country is caused by the Zaire Ebola virus species, according to Science magazine.
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, today announced the formation of a new task force to address drug shortages and long-term strategies for preventing them.
A new study by researchers with a health system in Detroit indicates that a small, behavioral "nudge" in microbiology reporting increased de-escalation and discontinuation of unnecessary broad-spectrum antibiotics in pneumonia patients. The results were reported in Open Forum Infectious Diseases.